Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQ
Status:
Completed
Trial end date:
2008-09-10
Target enrollment:
Participant gender:
Summary
This study is designed to observe the effects of a panic attack in patients with panic
disorders and to demonstrate the involvement of Substance P in panic disorder, and thereby,
further our understanding of its role in this illness. We will measure levels of Substance P
in the brain by obtaining pictures of the brain using PET and MRI....
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Mental Health (NIMH)
Treatments:
(2-fluoromethoxy-5-(5-trifluoromethyltetrazol-1-yl)benzyl)(2-phenylpiperidin-3-yl)amine Neurokinin A Substance P